Greenleaf Peter's Form 4 filing
Aurinia Pharmaceuticals Inc. (AUPH) · filed Mar 6, 2023
- Accession no.
- 0001628280-23-006526
- Filed
- Mar 6, 2023
- Trade date
- Mar 2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $292.8K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001600620-24-000013 (Feb 22, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenleaf PeterCIK 0001363683 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +667,407 | – | – | 1,015,718 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −32,750 | $8.94 | −$292,785 | 982,968 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.